Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

Favipiravir is approved in Japan to treat novel or re-emerging influenza viruses, and is active against a broad spectrum of RNA viruses, including Ebola. Ribavirin is the only other licensed drug with activity against multiple RNA viruses. Recent studies show that ribavirin and favipiravir act syner...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antiviral Res
Autori principali: Westover, Jonna B., Sefing, Eric J., Bailey, Kevin W., Van Wettere, Arnaud J., Jung, Kie-Hoon, Dagley, Ashley, Wandersee, Luci, Downs, Brittney, Smee, Donald F., Furuta, Yousuke, Bray, Mike, Gowen, Brian B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4724333/
https://ncbi.nlm.nih.gov/pubmed/26711718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2015.12.006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi